Dr. Yuval Cabilly is the co-founder and Managing Partner (also cited as General Partner) of Israel Biotech Fund. See sector focus and contact routes.
Dr. Yuval Cabilly is the co-founder and Managing Partner (also cited as General Partner) of Israel Biotech Fund, a venture capital firm dedicated to investing in exceptional Israeli pharmaceutical companies. The fund’s investment thesis focuses exclusively on Israeli and Israeli-related biotech companies across all development stages, with a specific commitment to maximizing the success of therapeutic assets. Israel Biotech Fund was established to raise between $50 million and $100 million, targeting Israel-based biotech startups. While the search results do not specify typical check sizes or whether Cabilly leads or follows on investments, the fund is helmed by him as the general partner. Notable portfolio companies include Pharma Two B and Tamarix, for which Cabilly serves on the Board of Directors, as well as his role as a board member at 8400 – The Health Network. Cabilly holds a PhD in molecular cell biology from Tel Aviv University, where his research focused on neurodegenerative diseases, providing a scientific foundation for his venture activities. The search results do not contain information regarding a distinctive point of view or public
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Israel.
Investors like Yuval Cabilly · Full investor directory · Investor access · Company funding database